CAS: 1369764-02-2 - (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide
Formula:C22H20F2N4O2
InChI:InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1
InChI key:InChIKey=MUGXRYIUWFITCP-PGRDOPGGSA-N
SMILES:O=C(NC1=NC=C(F)C=C1)C2CC2(C=3C=CC=C(F)C3)COC4=CN=C(N=C4C)C
- Sinonimi:
- (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide
- Dayvigo
- Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-
- E 2006
- Lemborexant
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Lemborexant REF: 4Z-L-211001CAS: 1369764-02-2 | - - - | Prezzo su richiesta | Ven 10 Gen 25 | |
Lemborexant-d3 REF: 4Z-L-211017CAS: 1369764-02-2 | - - - | Prezzo su richiesta | Gio 16 Gen 25 | |
Lemborexant REF: TR-L215945CAS: 1369764-02-2 | - - - | 209,00 €~1.572,00 € | Mar 21 Gen 25 | |
Lemborexant REF: 3D-FL103847CAS: 1369764-02-2 | Min. 98 Area-% | 136,00 €~521,00 € | Mar 21 Gen 25 |
Ref: 4Z-L-211001
10mg | Prezzo su richiesta | ||
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta | ||
100mg | Prezzo su richiesta |
Ref: 4Z-L-211017
10mg | Prezzo su richiesta | ||
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta | ||
100mg | Prezzo su richiesta |
Lemborexant
Prodotto ControllatoRef: TR-L215945
10mg | 209,00 € | ||
50mg | 911,00 € | ||
100mg | 1.572,00 € |
Lemborexant
Prodotto ControllatoRef: 3D-FL103847
1mg | 136,00 € | ||
2mg | 189,00 € | ||
5mg | 285,00 € | ||
10mg | 374,00 € | ||
25mg | 521,00 € |